IBD patients have been found to have a higher risk of lymphoma.

Published Date: 26 Apr 2023

According to researchers from the Karolinska Institutet, patients with Crohn's disease and IBD have an elevated risk of developing lymphoma, and this risk has grown over the past few years.

Read Full News

Latest News

Q&A: Managing GI Toxicities of Immunotherapy

Gastrointestinal side effects are among the most important issues to address with patients starting on immune checkpoint inhibitors.

Equitable IBD Care: Improving Interactions With Patients From the LGBTQ+ Community

Equitable IBD Care: Improving Interactions With Patients From the LGBTQ+ Community

Mastering Recent Advances in Targeted Therapy for GEP-NETs

Mastering Recent Advances in Targeted Therapy for GEP-NETs

Steatosis and Cardiovascular Events; Golimumab Biosimilar OK'd; Daily Stress and IBS

News and commentary from the world of gastroenterology and hepatology

GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

Accumulating evidence of possible benefit warrants randomized trials, experts say

Danish Duo's Maverick African Research Finds Its Moment in RFK Jr.'s Vaccine Policy

"They became more strident in saying that their findings were real," says one expert

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Latest News

Gastrointestinal side effects are among the most important issues to address with patients starting on immune checkpoint inhibitors.

Equitable IBD Care: Improving Interactions With Patients From the LGBTQ+ Community

Mastering Recent Advances in Targeted Therapy for GEP-NETs

News and commentary from the world of gastroenterology and hepatology

Accumulating evidence of possible benefit warrants randomized trials, experts say

"They became more strident in saying that their findings were real," says one expert

News All Time

Non-Operative Treatment for CRC May Include Observation After Complete Response

No difference in disease-free, overall survival compared with 3 years of maintenance therapy

Targeted Combo Boosts PFS in BRAF-Mutant Metastatic Colorectal Cancer

Adding encorafenib and cetuximab to chemotherapy backbone also prolonged overall survival

Saroglitazar Boosts Response Rates in Primary Biliary Cholangitis

More than half of patients saw a biochemical response by 1 year with the novel oral agent

Adding Immunotherapy-Based Combo Boosts PFS in Unresectable Liver Cancer

But is the higher incidence of grade 3/4 adverse events "a worthwhile price to pay?" expert asks

Large Study Links GLP-1s to Lower Risk of Multiple Cancers

Patients taking the drugs for obesity had a 41% lower risk of related cancers

Fart Frequency in Men vs Women; Organ Transplant in Celiacs; Engineered Gut Bacteria

News and commentary from the world of gastroenterology and hepatology

Study Warns on Sugary Drinks and Liver Cancer

However, no association between artificially sweetened drinks and liver cancer observed

Tolerability Concerns for GLP-1/Glucagon Agonist in Obesity, MASLD

Roughly one in five patients ditched survodutide due to adverse events

NICU Babies More Likely to Miss Rotavirus Vax

Study shows impact of guidelines' strict upper age limit and suggestion of delay until discharge

Study Linking Vaccines to Autism Retracted

Research was included in CDC's recent hepatitis B birth vaccination review

Gas-X Recall; MASLD and Alzheimer's Mortality; Counties Without a Gastroenterologist

News and commentary from the world of gastroenterology and hepatology

Study Flags Overuse of Antibiotics for Diverticulitis

Guidelines call for selective use in uncomplicated cases, but that's not happening at the VA

Red Wine and Bowel Disease; Transplant Paper Retracted; AGA Dumps on CRC Blood Test

News and commentary from the world of gastroenterology and hepatology

Advanced Therapy in Early Crohn's Disease: Evidence Outpaces Acceptance

Top-down strategy still hasn't vanquished traditional step-up approach

New Strategies and Platforms for Gastroesophageal Cancer

Antibody-drug conjugates, T-cell engagers, CAR T-cell therapy build on recent progress

Prenatal Exposure to Acid Suppressants and Kids' IBD Risk: No Need to Worry?

Exposure tied to modest increased risk of IBD, but with very low absolute risk

Recommended News For You

Kidney cancer: Understanding what a renal cell carcinoma diagnosis means

Bayer is transforming pharmaceutical research into women's health

Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

Guideline on management of early-stage non-small cell lung cancer released

CAR-T Warning for Secondary Malignancies: Warranted or Not?

AI tool identifies women at high risk of interval breast cancer

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.

Recommended Articles For You

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium 

An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025 

Exploring the Latest Advances in PTLD Cancer Treatment 

Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Watch for Psoriasis After Cancer Immunotherapy, Study Says

2.

AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence

3.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

4.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

5.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

1.

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms

2.

Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities

3.

Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine

4.

Glycopyrrolate: The Secret Weapon for Excessive Sweating 

5.

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

2.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

3.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

4.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot